Market Overview

UPDATE: Sterne Agee Upgrades Intuitive Surgical on More Balanced Risk/Reward

Related ISRG
FDA Clears da Vinci(R) System Use in Benign Base of Tongue Resection Procedures
Wedbush Sees 'Stabilized' Market For Intuitive Surgical, Inc.
Stocks Sell Off as Shift from Risk Persists (Fox Business)

In a report published Tuesday, Sterne Agee analyst Gregory P. Chodaczek upgraded the rating on Intuitive Surgical (NASDAQ: ISRG) from Underperform to Neutral, and raised the price target from $360.00 to $380.00.

In the report, Sterne Agee noted, “With ISRG shares down approximately 31% from its 2014 high, following a disappointing 1Q14 report, we are upgrading the stock to Neutral from Underperform as we view the risk/reward as more balanced at current levels. While we still believe dVH procedures volumes in the U.S. will be lower than 2013 and the da Vinci Xi roll out will be modest, we think the stock's current valuation has priced in these negative scenarios.”

Intuitive Surgical closed on Monday at $367.80.

Latest Ratings for ISRG

DateFirmActionFromTo
Sep 2014RBC CapitalInitiates Coverage onSector Perform
Jul 2014Raymond JamesUpgradesMarket PerformOutperform
Jul 2014Stifel NicolausUpgradesHoldBuy

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Gregory P. Chodaczek Sterne AgeeAnalyst Color Upgrades Analyst Ratings

 

Related Articles (ISRG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional